316|10000|Public
50|$|U.S. Patent Number 5,782,401: <b>The</b> <b>invention</b> <b>provides</b> an {{automated}} system for welding a first metal {{part to a}} second metal part. The system includes a trainable articulated arm.|$|E
50|$|In other words, <b>the</b> <b>invention</b> <b>provides</b> for {{flexibility}} in formulating a desired pricing system while reducing the prior art need to store, maintain, and retrieve {{huge amounts of}} data.|$|E
40|$|<b>The</b> <b>invention</b> <b>provides</b> polynucleotides {{and methods}} for {{detecting}} and quantifying RNA viruses, such as enteroviruses and noroviruses. In one aspect, <b>the</b> <b>invention</b> <b>provides</b> amplification primers and labeled molecular beacons for amplification of {{viral nucleic acid}} sequences. In another aspect, <b>the</b> <b>invention</b> <b>provides</b> a synthetic RNA internal control. In another aspect, <b>the</b> <b>invention</b> <b>provides</b> a kit for detecting the presence of enterovirus and/or norovirus in a sample...|$|E
40|$|Embodiments of <b>the</b> <b>invention</b> <b>provide</b> a {{dielectric}} elastomer {{composite material}} comprising {{a plurality of}} elastomer-coated electrodes arranged in an assembly. Embodiments of <b>the</b> <b>invention</b> <b>provide</b> improved force output over prior DEs by producing thinner spacing between electrode surfaces. This is accomplished by coating electrodes directly with uncured elastomer in liquid form and then assembling a finished component (which may be termed an actuator) from coated electrode components...|$|R
40|$|<b>The</b> present <b>invention</b> <b>provides</b> <b>the</b> cloning and {{expression}} of purified and isolated DNA molecules, obtainable from fungi, which encode enzymes having arabinan-degrading activity. <b>The</b> present <b>invention</b> also <b>provides</b> DNA constructs containing these DNA molecules and methods for their enhanced expression in selected microbial host cells. <b>The</b> present <b>invention</b> further <b>provides</b> methods {{for the use}} of the thus-produced arabinan-degrading enzyme...|$|R
40|$|<b>The</b> present <b>invention</b> {{is defined}} in the claims and {{provides}} methods and compositions for the in situ growth, freezing and testing of cultured cells. In particular, <b>the</b> present <b>invention</b> <b>provides</b> methods and compositions for the long-term preservation of cells in ready-to-use formats for testing. In addition, <b>the</b> present <b>invention</b> <b>provides</b> rapid {{and easy to use}} means to diagnose viral and other infections. Furthermore, <b>the</b> present <b>invention</b> <b>provides</b> easy to use means to grow and store cells in situ for testing methods. Indeed, <b>the</b> present <b>invention</b> makes viral, chlamydial and other diagnostic methods accessible to small laboratories, including those without cell culture capabilities...|$|R
40|$|<b>The</b> <b>invention</b> <b>provides</b> novel non-$g(b) -lactam inhibitors of $g(b) -lactamases. In particular, <b>the</b> <b>invention</b> <b>provides</b> such inhibitors {{which are}} boronic acids of formula (1) {{which is set}} forth in the specification. These {{compounds}} may be used with $g(b) -lactam antibiotics to treat $g(b) -lactam-antibiotic-resistant bacterial infections. Finally, <b>the</b> <b>invention</b> <b>provides</b> a pharmaceutical composition comprising these compound...|$|E
40|$|<b>The</b> <b>invention</b> <b>provides</b> {{a method}} of {{treating}} a. beta. -lactam-antibiotic-resistant bacterial infection {{with a combination of}} a. beta. -lactamanalog (acylaminomethaneboronic acid deriv.). The invention also provides {{a method of}} inhibiting a. beta. -lactamase comprising contacting the. beta. -lactamase with a. beta. -lactamanalog. Finally, <b>the</b> <b>invention</b> <b>provides</b> compds. which are. beta. -lactamanalogs and compns. contg.. beta. -lactam analogs...|$|E
40|$|<b>The</b> <b>invention</b> <b>provides</b> compounds, {{methods and}} uses {{suitable}} for modifying {{the characteristics of}} a plant, seed, or plant grown from the seed, by inhibiting jasmonate-mediated processes in the plant. In particular <b>the</b> <b>invention</b> <b>provides</b> jasmonate analogs, or other structurally related analogs, which function as antagonists. These can be used, for example, for improving disease resistance against one or more biotrophic or hemi-biotrophic pathogens, or for improving resistance against abiotic stress. Peer reviewedConsejo Superior de Investigaciones Científicas, Lipidox COA 1 Solicitud de adición a la patent...|$|E
40|$|<b>The</b> present <b>invention</b> <b>provides</b> methods, compositions, and kits wherein {{nanomaterials}} {{are used}} for inhibiting cancer stem cell division, colony formation, spheroid formation and self-renewal. <b>The</b> present <b>invention</b> also <b>provides</b> methods, compositions, and kits wherein nanomaterials {{are used for}} treating cancer, coating tumors, and inhibiting metastasis. <b>The</b> present <b>invention</b> also <b>provides</b> methods, compositions, and kits wherein nanomaterials are used for inducing cells to go into stasis. <b>The</b> present <b>invention</b> further <b>provides</b> methods for isolating tumors, inhibiting bleeding, and marking margins of tumors and organs during surgery with a nanomaterial. published_or_final_versio...|$|R
40|$|<b>The</b> present <b>invention</b> <b>provides</b> {{systems and}} methods to {{automatically}} analyze Landsat satellite data of forests. <b>The</b> present <b>invention</b> {{can easily be}} used to monitor any type of forest disturbance such as from selective logging, agriculture, cattle ranching, natural hazards (fire, wind events, storms), etc. <b>The</b> present <b>invention</b> <b>provides</b> a large-scale, high-resolution, automated remote sensing analysis of such disturbances...|$|R
40|$|<b>The</b> present <b>invention</b> <b>provides</b> {{compositions}} {{and methods}} for modulating the secretion of transcriptionally regulated proteins from recombinant cells. More particularly, <b>the</b> present <b>invention</b> <b>provides</b> {{compositions and methods}} for accelerating the secretion dynamics of human insulin from recombinant cells using nonsense mediated mRNA decay of the preproinsulin mRNA transcript. Georgia Tech Research Corporatio...|$|R
40|$|The present {{invention}} {{provides an}} efficient gene delivery system using Adeno-Associated Viral (AAV) vector in gene therapy. Furthermore, <b>the</b> <b>invention</b> <b>provides</b> a combined AAV and Adenovirus (Adv) cocktail gene delivery system which {{is even more}} efficient in in vivo gene delivery and expression without eliciting any significant immune responses in an immunocompetent subject. In particular, <b>the</b> <b>invention</b> <b>provides</b> a therapeutic agent and methods for preventing, treating, managing, or ameliorating various diseases and disorders including, but not limited to, bone diseases, by delivering Bone Morphogenetic Protein 2 (BMP- 2) for new bone formation via gene therapy using said system. <b>The</b> <b>invention</b> <b>provides</b> a nucleic acid molecule comprising an AVV vector and a promoter operably linked to a sequence encoding BMP- 2; and a nucleic acid molecule comprising an Adv vector and a promoter operably linked to a sequence encoding BMP- 2, as well as vectors and host cells comprising said nucleic acid molecules, respectively. published_or_final_versio...|$|E
40|$|The present {{invention}} {{relates to}} maskless photolithography using a patterned light generator for creating 2 -D and 3 -D patterns on objects using photoreactive chemicals. In an embodiment, the patterned light generator uses a micromirror array to direct pattern {{light on a}} target object. In an alternate embodiment, the patterned light generator uses a plasma display device to generate and direct patterned light onto a target object. Specifically, <b>the</b> <b>invention</b> <b>provides</b> a maskless photolithography system and method for creating molecular imprinted array devices, integrated microsensors and fluidic networks on a substrate, integrated circuits of conducting polymers, and patterns on substrates using photochemical vapor deposition. For creating molecular imprinted array devices, <b>the</b> <b>invention</b> <b>provides</b> a system and method for applying a photoreactive reagent comprising photopolymer receptors and extractable target compounds, exposing the substrate to patterned light to activate the photopolymer to form molecular imprints of the target compounds corresponding to the pattern of incident light. For creating integrated circuits of conducting polymers, <b>the</b> <b>invention</b> <b>provides</b> a system and method for applying a photoreactive conducting polymer reagent to a substrate, exposing the substrate to patterned light to activate the photoreactive conducting polymer reagent to form integrated circuits corresponding to the circuit pattern of incident light. In an embodiment the substrate is a photoreactive conductive polymer. For creating integrated microsensors and fluidic networks on a substrate, <b>the</b> <b>invention</b> <b>provides</b> a system and method for applying a photoreactive sensor creating compound and a photoreactive fluid channel creating compound to a substrate, exposing the substrate to patterned light to activate the photoreactive compounds to form microsensor arrays and fluidic networks corresponding to the pattern of incident light. For creating patterns on substrates using photochemical vapor deposition, <b>the</b> <b>invention</b> <b>provides</b> a system and method for exposing a substrate to photoreactive gases and patterned light to deposit chemicals on the substrate corresponding to the pattern of incident light...|$|E
40|$|The present {{invention}} {{relates to}} an isolated novel virus causing Severe Acute Respiratory Syndrome (SARS) in humans ("hSARS virus"). The hSARS virus is identified to be morphologically and phylogenetically similar to known member of Coronaviridae. The present invention provides the complete genomic {{sequence of the}} hSARS virus. Furthermore, <b>the</b> <b>invention</b> <b>provides</b> the nucleic acids and peptides encoded by and/or derived from the hSARS virus and their use in diagnostic methods and therapeutic methods, including vaccines. In addition, <b>the</b> <b>invention</b> <b>provides</b> chimeric or recombinant viruses encoded by said nucleotide sequences and antibodies immunospecific to the polypeptides encoded by the nucleotide sequences. published_or_final_versio...|$|E
40|$|<b>The</b> subject <b>invention</b> {{pertains}} to vaccine formulations and antibodies, and related methods, {{for the treatment}} and/or prevention of S. aureus infection. <b>The</b> present <b>invention</b> <b>provides</b> one or more S. aureus antigens for use in vaccine formulations, wherein two or more antigens act synergistically. Further, <b>the</b> present <b>invention</b> <b>provides</b> vaccines that can protect against hematic spread, pneumonia and skin infection. published_or_final_versio...|$|R
40|$|<b>The</b> present <b>invention</b> <b>provides</b> a novel polypeptide, Connective Tissue Growth Factor (CTGF), polynucleotides {{encoding}} CTGF and polynucleotides regulating CTGF expression. <b>The</b> <b>invention</b> also <b>provides</b> {{agents that}} modulate CTGF and therapeutic methods {{for using the}} agents. Also provided are diagnostic methods for using CTGF and assays for identifying agents which affect the expression of CTGF polynucleotide...|$|R
40|$|<b>The</b> present <b>invention</b> <b>provides</b> for {{a digital}} {{holographic}} microscope using a holographic interferometer and incorporating a TIR sample mount and microscopic imaging optics. The microscope uses phase shifting from frustrated internal reflection within a prism to measure nanometric distances. <b>The</b> <b>invention</b> also <b>provides</b> for a numerical reconstruction algorithm of an inclined {{surface of the}} object/prism...|$|R
40|$|The Present Invention Relates To An Isolated Novel Virus Causing Severe Acute Respiratory Syndrome (Sars) In Humans ("Hsars Virus"). The Hsars Virus Is Identified To Be Morphologically And Phylogenetically Similar To Known Member Of Coronaviridae. The Present Invention Provides The Complete Genomic Sequence Of The Hsars Virus. Furthermore, <b>The</b> <b>Invention</b> <b>Provides</b> The Nucleic Acids And Peptides Encoded By And/Or Derived From The Hsars Virus And Their Use In Diagnostic Methods And Therapeutic Methods, Including Vaccines. In Addition, <b>The</b> <b>Invention</b> <b>Provides</b> Chimeric Or Recombinant Viruses Encoded By Said Nucleotide Sequences And Antibodies Immunospecific To The Polypeptides Encoded By The Nucleotide Sequences. published_or_final_versio...|$|E
40|$|The present {{invention}} {{relates to}} an isolated novel virus causing Severe Acute Respiratory Syndrome (SARS) in humans ('hSARS virus'). The hSARS virus is identified to be morphologically and phylogenetically similar to known member of Coronaviridae. The present invention provides the complete genomic {{sequence of the}} hSARS virus. Furthermore, <b>the</b> <b>invention</b> <b>provides</b> the nucleic acids and peptides encoded by and/or derived from the hSARS virus and their use in diagnostic methods and therapeutic methods, including vaccines. In addition, <b>the</b> <b>invention</b> <b>provides</b> chimeric or recombinant viruses encoded by said nucleotide sequences and antibodies immunospecific to the polypeptides encoded by the nucleotide sequences. published_or_final_versio...|$|E
40|$|The present {{invention}} {{relates to}} fullerene, nanotube, or nanofiber filled metals and polymers. This invention {{stems from a}} cross-disciplinary combination of electromagnetic and acoustic processing and property enhancement of materials through fullerene or nanofiber additives. Containerless processing (CP) {{in the form of}} electromagnetic field enduced and/or acoustic mixing leads to controlled dispersion of fullerenes, nanotubes, or nanofibers in various matrices. <b>The</b> <b>invention</b> <b>provides</b> methods of mixing that highly disperse and align the fullerenes, nanotubes, or nanofibers within the matrices of metals and polymers. <b>The</b> <b>invention</b> <b>provides</b> new compositions of matter and multifunctional materials based on processing, composition, and degree of in situ processing...|$|E
40|$|Embodiments of <b>the</b> <b>invention</b> <b>provide</b> {{a method}} of making non-spherical {{nanoparticles}} that includes (a) combining a source of a Group 12, 13, 14, or 15 metal or metalloid; a source of a Group 15 or 16 element; {{and a source of}} a quaternary ammonium compound or phosphonium compound; and (b) isolating non-spherical nanoparticles from the resulting reaction mixture. Other embodiments of <b>the</b> <b>invention</b> <b>provide</b> non-spherical nanoparticle compositions, that are the reaction product of a source of a Group 12, 13, 14, or 15 metal or metalloid; a source of a Group 15 or 16 element; and a source of a quaternary ammonium compound or phosphonium compound; wherein nanoparticle tetrapods comprise 75 - 100 number percent of the nanoparticle products...|$|R
40|$|<b>The</b> present <b>invention</b> <b>provides</b> for {{a system}} and method whereby aspirin and acetic acid help to permeabilize cell {{membranes}} to allow exogenous molecules {{to gain access to}} the cell interior. As such, <b>the</b> present <b>invention</b> <b>provides</b> a low cost drug and gene delivery tool that can be applied in combination with other molecular delivery methods...|$|R
40|$|<b>The</b> present <b>invention</b> <b>provides</b> {{materials}} and methods useful to treat various sGCα 1 -expressing cancers. Materials include peptides which interfere with sGCα 12 ̆ 7 s pro-survival functions, thereby resulting in apoptosis of sGCα 1 -expressing cells. In addition, <b>the</b> present <b>invention</b> <b>provides</b> screening assays, diagnostic assays, methods to prognose, methods to treat, and kits...|$|R
40|$|<b>The</b> <b>invention</b> <b>provides</b> {{a process}} for {{remediation}} of sites contaminated with metals such as former industrial sites and mines. In particular <b>the</b> <b>invention</b> <b>provides</b> {{a process for}} site remediation comprising the steps of: (a) adding metal-binding particles to a site containing one or more metal contaminants such {{that at least some}} of the one or metal contaminants are sequestered by the particles, and (b) populating the site with plants. The use of the particles of the present invention in association with plants, and microbiota associated with the plant roots can achieve sustainable phytostabilisation of contaminated sites...|$|E
40|$|The present {{invention}} {{relates to}} maskless photolithography using a patterned light generator for creating 2 -D and 3 -D patterns on objects using etching and deposition techniques. In an embodiment, the patterned light generator uses a micromirror array to direct pattern {{light on a}} target object. In an alternate embodiment, the patterned light generator uses a plasma display device to generate and direct patterned light onto a target object. Specifically, <b>the</b> <b>invention</b> <b>provides</b> a maskless photolithography system and method for photo stimulated etching of objects in a liquid solution, patterning glass, and photoselective metal deposition. For photo stimulated etching of objects in a liquid solution, <b>the</b> <b>invention</b> <b>provides</b> a system and method for immersing a substrate in an etchant solution, exposing the immersed substrate to patterned light, and etching the substrate according to the pattern of incident light. For patterning photoreactive glass, <b>the</b> <b>invention</b> <b>provides</b> a system and method for exposing photosensitive or photochromic glass, and washing the target glass with rinse and acid etchant solutions. For photoselective metal deposition, <b>the</b> <b>invention</b> <b>provides</b> a system and method for coating and rinsing a substrate prior to exposure exposing the substrate to a patterned light generator to activate areas corresponding to the incident light pattern, and plating the substrate in the area activated by the light after exposure. By providing a maskless pattern generator, the invention advantageously eliminates {{the problems associated with}} using masks for photo stimulated etching, patterning glass, and photoselective metal deposition...|$|E
40|$|<b>The</b> <b>invention</b> <b>provides</b> an {{isolated}} or {{recombinant nucleic acid}} derived from a nucleic acid encoding a polypeptide essentially having alpha-glucanotransferase activity but having essentially no hydrolysing activity, said isolated or recombinant nucleic acid encoding a polypeptide with hydrolytic activity...|$|E
40|$|<b>The</b> present <b>invention</b> <b>provides</b> a {{bacterial}} strain which {{is able to}} degrade or mineralize s-triazine compounds, such as simazine, which corresponds to Pseudomonas sp. strain MHP 41, deposited under the accession number NRRL B- 30908. <b>The</b> present <b>invention</b> <b>provides</b> a product for the bioremediation of environments contaminated with s-triazine, where the product includes {{a bacterial}} inoculum of Pseudomonas sp. strain MHP 41. <b>The</b> present <b>invention</b> further <b>provides</b> a method for the bioremediation of environments contaminated with s-triazines, which uses this product for the bioremediation...|$|R
40|$|<b>The</b> Present <b>Invention</b> <b>Provides</b> Methods Of Screening For Anti-Cancer Drugs Based On The Activities Of Overexpressed Enzymes By The Cancer Cells To Convert Non-Toxic Compounds To Cytotoxic Drugs Which Can Specifically Kill These Cancer Cells. In Particular, <b>The</b> Present <b>Invention</b> <b>Provides</b> Methods Of Screening For Anti-Cancer Drugs Which Can Be Used To Treat Liver Cancer, Especially Hepatocellular Carcinoma. <b>The</b> Present <b>Invention</b> Also <b>Provides</b> Methods Of Treating Cancers, In Particular Liver Cancer, Especially Hepatocellular Carcinoma, By Administering To A Subject The Drugs Selected By The Screning Methods Of <b>The</b> Present <b>Invention.</b> In A Particular Embodiment, Naphthalene Or A Derivative Thereof Is Administered To A Subject. <b>The</b> Present <b>Invention</b> Further <b>Provides</b> Pharmaceutical Compositions For Treating Or Ameliorating Cancers As Well As Kits Containing Such Compositions. link_to_OA_fulltex...|$|R
40|$|<b>The</b> present <b>invention</b> <b>provides</b> {{methods of}} {{screening}} for anti-cancer drugs {{based on the}} activities of overexpressed enzymes by the cancer cells to convert non-toxic compounds to cytotoxic drugs which can specifically kill these cancer cells. In particular, <b>the</b> present <b>invention</b> <b>provides</b> methods of screening for anti-cancer drugs {{which can be used}} to treat liver cancer, especially hepatocellular cercinoma. <b>The</b> present <b>invention</b> also <b>provides</b> methods of treating cancers, in particular liver cancer, especially hepatocellular carcinoma, by administering to a subject the drugs selected by the screning methods of <b>the</b> present <b>invention.</b> In a particular embodiment, naphthalene or a derivative thereof is administered to a subject. <b>The</b> present <b>invention</b> further <b>provides</b> pharmaceutical compositions for treating or ameliorating cancers as well as kits containing such compositions. published_or_final_versio...|$|R
40|$|<b>The</b> <b>Invention</b> <b>Provides</b> N,N'-Disubstituted Monothiourea Or Bis-Thiourea-Pd(0) Complexes That Are Useful As Catalysts For Palladium-Catalyzed Heck Reaction Of Aryl Iodides And Bromides With Olefins, And As Catalysts For Palladium Catalyzed Suzuki Reactions Of Organoboric Compounds And Aryl Halides. published_or_final_versio...|$|E
40|$|<b>The</b> <b>invention</b> <b>provides</b> N,N'-disubstituted monothiourea or bisthiourea-Pd(0) {{complexes}} {{that are}} useful as catalysts for palladium-catalyzed Heck reaction of aryl iodides and bromides with olefins, and as catalysts for palladium catalyzed Suzuki reactions of organoboric compounds and aryl halides (Formula A). published_or_final_versio...|$|E
40|$|<b>The</b> <b>Invention</b> <b>Provides</b> Organic Thin Film Transistors Including Quinacridone Derivatives With Formula (I). These Otfts Are Useful In Making Flat Panel Displays, Photovoltaic Devices And Sensors. In The Present Invention, The Disclosed Quinacridone Derivatives Exhibit As P-Type Organic Semiconductors In Otfts. link_to_OA_fulltex...|$|E
40|$|<b>The</b> present <b>invention</b> <b>provides</b> new Ag(I) {{complexes}} with derivatives of nicotinic acid, nicotinamide {{and related}} pyridine ligands, and pharmaceutical compositions comprising such Ag(I) complexes {{for use in}} the treatment, prophylaxis and prevention of infections. <b>The</b> <b>invention</b> further <b>provides</b> a solvent free method for the synthesis of Ag(I) complexes containing substituted pyridines, pyrazines and pyrimidines as ligands...|$|R
40|$|<b>The</b> present <b>invention</b> {{relates to}} {{secretion}} in Gram-positive microorganisms. <b>The</b> present <b>invention</b> <b>provides</b> <b>the</b> nuclei acid and amino acid sequences for the Bacillus subtilis disulfide bond isomerases, Dsb 1 and Dsb 2. <b>The</b> present <b>invention</b> also <b>provides</b> means {{for increasing the}} secretion of heterologous or homologous proteins in gram-positive microorganisms...|$|R
40|$|In one embodiment, <b>the</b> present <b>invention</b> <b>provides</b> {{methods of}} {{modulating}} the deacetylase activity of SIRT 1 {{in one or}} more cell by modifying the binding affinity of lamin A to SIRT 1 via one or more interaction modifying compound. In another embodiment, <b>the</b> present <b>invention</b> <b>provides</b> methods of screening SIRT 1 -activating/inhibiting compounds based on the interaction between lamin A and SIRT 1 proteins and SIRT 1 -activating property of lamin A. In another embodiment, <b>the</b> present <b>invention</b> <b>provides</b> uses of SIRT 1 -activating compounds to treat patient(s) suffering from metabolic and/or aging-related degenerative diseases, and uses of SIRT 1 -inhibiting compounds to treat human malignancies. published_or_final_versio...|$|R
